Clinical trial
Prospective Sample Collection Study for Discovery and Evaluation of Novel Blood Based Biomarkers for Assessment of Hepatic Fibrosis
NCT06819917 is registered in ClinicalTrials.gov with Roche Diagnostics GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Sample Collection Study for Discovery and Evaluation of Novel Blood Based Biomarkers for Assessment of Hepatic Fibrosis
- Lead sponsor
- Roche Diagnostics GmbH
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 1, 2025
- Completion date
- December 31, 2026
- Enrollment
- 575 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
non-alcoholic fatty liver, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis